About Us

Centerphase is a new technology-enabled services company focused on leveraging electronic health information and innovative operating procedures to accelerate the clinical development process. With over 75 years of experience in the biopharma industry, we have experienced first-hand the consequences of trials that cannot be executed by the selected sites or within the desired timelines. At Centerphase, we have drawn from these real-world experiences to directly take on the root causes historically plaguing the clinical trials process.

Centerphase was initiated through a unique collaboration between the founders of Merck's venture capital group and Mayo Clinic. Centerphase has created a series of proprietary analytic tools and operating procedures to leverage the superior information technology and clinical capabilities of Mayo Clinic and other leading Academic Medical Centers (AMCs) to deliver timely and predictable study execution to the biopharmaceutical industry. With an extensive background in biopharmaceuticals, the Centerphase team recognizes the critical importance of designing an executable study from the start and optimizing all related processes.